Gilead Sciences Inc. (GILD): Price and Financial Metrics

GILD POWR Grades

• GILD scores best on the Value dimension, with a Value rank ahead of 97.15% of US stocks.
• GILD's strongest trending metric is Stability; it's been moving up over the last 177 days.
• GILD's current lowest rank is in the Momentum metric (where it is better than 3.78% of US stocks).

GILD Stock Summary

• With a market capitalization of $93,463,536,619, GILEAD SCIENCES INC has a greater market value than 97.66% of US stocks.
• GILD's went public 31.7 years ago, making it older than 83.38% of listed US stocks we're tracking.
• In terms of volatility of its share price, GILD is more volatile than merely 3.85% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to GILEAD SCIENCES INC, a group of peers worth examining would be ADI, NTES, BMY, ATVI, and RTX.
• GILD's SEC filings can be seen here. And to visit GILEAD SCIENCES INC's official web site, go to www.gilead.com.

GILD Valuation Summary

• In comparison to the median Healthcare stock, GILD's price/sales ratio is 15% lower, now standing at 3.4.
• Over the past 243 months, GILD's price/sales ratio has gone down 13.1.

Below are key valuation metrics over time for GILD.

GILD Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -60.73%.
• Its 5 year net cashflow from operations growth rate is now at -41.74%.
• The 5 year net income to common stockholders growth rate now stands at -60.73%.

Over the past 34 months, GILD's revenue has gone up $4,565,000,000.

The table below shows GILD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	27,281	9,072	4,592
2022-09-30	27,136	9,710	3,334
2022-06-30	27,515	10,100	4,137
2022-03-31	27,472	10,614	4,515
2021-12-31	27,305	11,384	6,225
2021-09-30	27,482	10,095	7,394

GILD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• GILD has a Quality Grade of B, ranking ahead of 89.87% of graded US stocks.
• GILD's asset turnover comes in at 0.406 -- ranking 114th of 682 Pharmaceutical Products stocks.
• ENTA, RDUS, and ADMS are the stocks whose asset turnover ratios are most correlated with GILD.

The table below shows GILD's key quality metrics over time.